Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
NCT01681524
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
delayed study start
Conditions
Coronary Artery Disease
Interventions
DRUG:
Flurpiridaz F18
Sponsor
Lantheus Medical Imaging